Fine Organic Industries (FINEORG) Q4 21/22 earnings summary

Executive summary

• FY22 delivered strong growth despite COVID-19 waves and cost inflation: standalone revenue rose 65.74% YoY, EBITDA 81.46% and PAT 120.46%.

• Growth strategy centers on oleochemical-based green additives, R&D-led product development, geographic expansion and higher-value applications; products serve 75+ countries across multiple industries.

Financial highlights

• Standalone revenue from operations reached ₹185,842.83 lakh vs ₹112,129.01 lakh; EBITDA was ₹34,852.40 lakh vs ₹19,206.95 lakh.

• Standalone PAT was ₹25,066.93 lakh vs ₹11,493.18 lakh; PBT rose to ₹33,676.72 lakh from ₹15,623.88 lakh.

• Consolidated revenue was ₹187,625.92 lakh vs ₹113,321.84 lakh; consolidated PAT was ₹25,970.91 lakh vs ₹12,034.13 lakh.

• Standalone operating cash flow was ₹4,972.01 lakh vs ₹13,509.23 lakh, with working-capital movements absorbing cash amid higher inventories and receivables.

Outlook and guidance

• Strategic priorities include expanding presence in Gujarat, adding capacity at existing facilities, upgrading technology and processes, and developing new and existing product lines.

• Focus remains on product innovation, newer application areas, geographic reach, capacity utilisation and customer service; management expressed optimism about future free cash flow and shareholder returns.

• No numerical FY23 financial guidance was stated; stated plans emphasize sustainable growth and capacity expansion.